Meditor Group Ltd Q4 2023 significant ownership

Add to watchlist

Meditor Group Ltd is required to file a 13D/G report to the SEC when the ownership of a company's total stock issue exceeds 5%.

Meditor Group Ltd Q4 2023 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
EXELIXIS, INC.April 09, 201915,001,0735.0%
VIVUS INCDecember 19, 20125,002,8965.0%
VIVUS INCMarch 21, 20126,177,5006.3%
VION PHARMACEUTICALS INCFebruary 15, 20085,736,2007.6%
CYPRESS BIOSCIENCE INCSeptember 26, 20071,864,6455.0%
ONYX PHARMACEUTICALS INCSeptember 12, 20072,627,8004.8%
ACUSPHERE INCJuly 26, 20071,839,4214.0%
NOVACEA INCJune 11, 2007800,0003.4%
ATHEROGENICS INCMay 02, 20071,361,8003.5%

Compare quarters

Export Meditor Group Ltd's holdings

CSVXLS